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Abstract
Background: HIV-associated subacute meningitis is mostly caused by tuberculosis or cryptococcosis, but often no etiology
can be established. In the absence of CT or MRI of the brain, toxoplasmosis is generally not considered as part of the
differential diagnosis.
Methodology/Principal Findings: We performed cerebrospinal fluid real time PCR and serological testing for Toxoplasma
gondii in archived samples from a well-characterized cohort of 64 HIV-infected patients presenting with subacute meningitis
in a referral hospital in Indonesia. Neuroradiology was only available for 6 patients. At time of presentation, patients
mostly had newly diagnosed and advanced HIV infection (median CD4 count 22 cells/mL), with only 17.2% taking ART, and
9.4% PJP-prophylaxis. CSF PCR for T. Gondii was positive in 21 patients (32.8%). Circulating toxoplasma IgG was present in
77.2% of patients tested, including all in whom the PCR of CSF was positive for T. Gondii. Clinically, in the absence of
neuroradiology, toxoplasmosis was difficult to distinguish from tuberculosis or cryptococcal meningitis, although CSF
abnormalities were less pronounced. Mortality among patients with a positive CSF T. Gondii PCR was 81%, 2.16-fold higher
(95% CI 1.04–4.47) compared to those with a negative PCR.
Conclusions/Significance: Toxoplasmosis should be considered in HIV-infected patients with clinically suspected subacute
meningitis in settings where neuroradiology is not available.
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Introduction
In settings of Africa and Asia, the most common cause of
subacute meningitis in patients with advanced HIV infection is
either tuberculous or cryptococcal infection [1,2]. However, in
many patients, the etiology of subacute meningitis cannot be
established [1,3]. In line with a large retrospective cohort of adult
meningitis patients in South Africa, where 52.8% had no definite
diagnosis despite extensive microbiological testing [1], we could
not identify the causative pathogen in 48.9% of HIV-infected
meningitis patients in an Indonesian setting [4].
Toxoplasmosis is a common and serious central nervous system
(CNS) infection in patients with advanced HIV infection [5–8],
although its incidence has decreased with introduction of
antiretroviral treatment (ART) [6,9]. Cerebral toxoplasmosis
mostly presents as cerebral mass lesions with headache, confusion,
fever, lethargy, seizures, cranial nerve palsies, psychomotor
changes, hemiparesis and/or ataxia [10]. Some of these symptoms
may also mimic meningitis, but cerebral toxoplasmosis is generally
not considered as a differential diagnosis of subacute meningitis in
HIV-infected patients. This is especially the case in low-resource
settings where no CT or MRI can be performed. We have
therefore examined if toxoplasmosis can be diagnosed in HIV-
infected patients presenting with subacute meningitis of unknown
origin in Indonesia, using cerebrospinal fluid (CSF) PCR for T.
gondii.
Methods
Ethics statement
Anonymized CSF and blood samples were used from an
already-existing hospital collection, from a cohort of patients
collected as part of a project ‘Optimization of diagnosis of
meningitis’, approved by the Ethical Committee of Hasan Sadikin
Hospital/Medical Faculty of Universitas Padjadjaran, Bandung,
Indonesia (No. 85/FKUP-RSHS/KEPK/Kep/EC/2006). As this
study was done using already existing sample collection, no
separate consent was asked for this study. HIV testing is done
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routinely with oral informed consent for all patients with suspected
meningitis in Hasan Sadikin hospital, after 24% were found HIV-
positive in a previous cohort study of 185 patients in the same
hospital [4]. Consent is obtained from closest relatives (husband/
wife or parents) for those patients who are unstable or unconscious
at time of presentation. With approval from the ethical committee
HIV testing was done anonymously afterwards for those who had
died before consent could be obtained.
Setting and patients
We included adult patients presenting with suspected meningitis
at Hasan Sadikin Hospital, the top referral hospital for West Java
Province, Indonesia, between December 2006 and October 2010.
Clinical data including outcome was recorded in individual case
report form. Definite TB meningitis was diagnosed if CSF culture
or real time PCR were positive for M. tuberculosis, cryptococcal
meningitis if either CSF India Ink examination, culture or
cryptococcal antigen testing were positive, and toxoplasmosis if
CSF T. gondii PCR was positive. HIV testing is done routinely for
patients presenting at this hospital, but cerebral CT-scanning is
rarely done in this setting and is not covered by the government
health insurance for the poor.
Laboratory examinations
CSF cell count and differentiation, protein and glucose were
measured. CSF microscopy was done for cryptococci, acid-fast
bacilli and bacterial pathogens. CSF was cultured for Mycobacterium
tuberculosis (solid Ogawa and liquid MB-BacT, Biomerieux),
bacterial pathogens (blood agar, chocolate agar, and brain-heart
infusion) and fungi (Sabouraud). Cryptococcal antigen (CALAS,
Meridian Diagnostics) testing was done on CSF samples following
the manufacturer’s instructions. Five to 7 ml CSF samples were
used for molecular testing. After centrifugation of CSF samples at
30006g for 10 minutes, DNA was extracted from 200 ml of CSF
sediment by using QIAmp DNA mini kit (Qiagen, USA). CSF M.
tuberculosis real time PCR was done using IS6110, a repeated
insertion sequence specific for M. tuberculosis, as a target [11].
Measurement of CD4-cell count for HIV-patients only became
available during the time of the study and was measured only for
those who survived for more than 4 days. Real time PCR for T.
gondii, using the multicopy B1 gene of the T. gondii as the target as
described elsewhere [12], was performed to archived CSF samples
at Radboud University Nijmegen Medical Centre. CSF specimens
from 22 HIV-negative meningitis patients (16 with definite TB
meningitis, 2 with bacterial meningitis, and 4 with no definite
diagnosis), and nine patients with non-infectious CNS diseases, all
recruited at Hasan Sadikin Hospital, were used as controls for T.
gondii PCR. These samples were collected during the study period
over a similar time scale compared to the case CSF samples.
Toxoplasma immunoglobuline G (toxoplasma IgG) were mea-
sured by electro chemiluminescent assay (ECLIA, Elecsys, Roche)
in archived serum samples of patients included in the study.
Data analysis and statistics
Characteristics of patients with definite tuberculosis, cryptococ-
cosis and toxoplasmosis were compared using Chi-square test for
proportions and Mann-Whitney U test for continuous variables.
Progression to death using 2-month mortality data was examined
by Kaplan–Meier estimates.
Results
During the period, 401 patients presented with clinical
meningitis, 76 were diagnosed with HIV infection, and 64 had
archived CSF samples and were included in this study. Patients
included in the study presented after a median 7 days, with
meningismus (86.0%), headache (80.8%), lowered consciousness
(33.3%), fever (28.8%), hemi- or tetraparesis (28.6%), cranial nerve
palsies (12.5%), and seizures (10.9%). HIV was newly diagnosed in
53 patients (82.8%). All 11 patients previously diagnosed with HIV
were taking ART, and 6 were using co-trimoxazole as Pneumocystis
jiroveci (PJP) prophylaxis at time of presentation. The median CD4
cell count was 22 cells/mL, and less than 200 cells/mL in 22 out of
23 patients tested (96%).
CSF T. gondii PCR was positive in 21 of 64 HIV-infected
patients (32.8%), with a median Ct-value of 36.0 (IQR: 34.2–39.3).
None of the 22 HIV-negative control and 9 non-infectious CNS
disease patients had a positive T. gondii PCR. Archived serum
sample was not available in 14 patients. Toxoplasma IgG was
positive in 78% of patients tested, including all patients with
positive CSF T. gondii PCR. Toxoplasma IgG titers were higher
among patients with a positive CSF T. gondii PCR (p= .017). A
definite diagnosis of TB meningitis was established in 21/64
patients (32.8%). Out of 21 patients with positive T. gondii PCR,
five had combined tuberculosis and toxoplasmosis. Cryptococcosis
was diagnosed in 15/64 patients (23.4%), including two who were
also diagnosed with tuberculosis. In 14 patients (21.9%) no
causative pathogen was isolated.
Neck stiffness, headache and fever, the classical signs of
meningitis, were equally common in patients diagnosed with
toxoplasmosis, cryptococcosis and tuberculosis, as were most other
signs and symptoms, except hemiparesis (Table 1). None of the
patients with toxoplasmosis had received ART or co-trimoxazole
prophylaxis prior to admission with meningitis. CT scans were
available for 6 patients, including 4 with a positive T. gondii PCR.
Three showed signs of hydrocephalus, one a hypodense lesion that
showed no enhancement using contrast, and two were normal. No
mass lesions typical for cerebral toxoplasmosis were seen.
CSF cell count and protein were normal or mildly elevated
in patients with toxoplasmosis, and hypoglycorrhachia was less
common compared with tuberculosis or cryptococcosis
Author Summary
If HIV-infected patients present with seizures, focal
neurological symptoms or confusion, a CT-scan or MRI of
the brain is normally made. If mass lesions are found (and
the CD4 cell count is sufficiently low), cerebral toxoplas-
mosis is suspected, and often treated empirically. Howev-
er, some of the symptoms of cerebral toxoplasmosis may
mimic those of subacute meningitis. Therefore, in settings
where no cerebral imaging can be performed, HIV-
associated cerebral toxoplasmosis may be under-diag-
nosed. We retrospectively looked for toxoplasmosis in a
cohort of HIV-infected patients presenting with subacute
meningitis in an Indonesian hospital, where neuroradiol-
ogy was not available for most patients. Patients mostly
came with newly diagnosed and advanced HIV infection
and few were on HIV-treatment or PJP-prophylaxis.
Molecular testing of cerebrospinal fluid (CSF) was positive
for Toxoplasma gondii in 32% of patients, serology was
positive in 78%. Clinically, in the absence of neuroradiol-
ogy, toxoplasmosis was difficult to distinguish from
tuberculosis or cryptococcal meningitis. A positive CSF T.
gondii PCR was associated with a two-fold increased
mortality. We conclude that toxoplasmosis should be
considered in HIV-infected patients with clinically suspect-
ed subacute meningitis in settings where neuroradiology
is not available.
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(Table 1). CD4 counts, missing in two-thirds of patients due to
early death or the unavailability of CD4 cell testing during the
initial phase of the cohort study, were low in all but one
patient. Table 2 lists the CSF findings of individual patients,
Figure 1 is a graphic representation of the CSF cell count,
protein and glucose ratio, showing the overlap in CSF findings
Table 1. Characteristics of patients according to microbiological diagnosis.
Tuberculosis (n= 14) Cryptococcosis (n =13) Toxoplasmosis (n=16)
General
Age in year – median (IQR) 30 (27–34) 30 (27–32) 31 (28–33)
Male sex – no. (%) 11 (78.6) 11 (84.6) 11 (68.8)
History of TB treatment – no. (%) 3 (21.4) 3 (23.1) 4 (25.0)
Duration of illness, days – median (IQR) 14 (6–28) 7 (2–14) 7 (4–12)
ART prior to admission – no. (%) 2 (14.3) 4 (30.8) 1 (6.3)
PJP-prophylaxis – no. (%) 0 3 (23.1) 0
Signs and symptoms on presentation
Headache – no. (%) 10/12 (83.3) 10/11 (90.9) 10/12 (83.3)
Seizure – no. (%) 0/13 (0.0) 2/11 (18.2) 2/13 (15.4)
Neck stiffness – no. (%) 12/13 (92.3) 9/11 (81.8) 13/16 (81.3)
Body temperature $38uC – no. (%) 4/11 (36.4) 1/8 (12.5) 4/13 (30.8)
Altered consciousness (GCS,14) – no. (%) 6/10 (60.0) 2/10 (20.0) 4/10 (40.0)
GCS – median (range) 13 (6–15) 15 (9–15) 14 (12–15)
Hemi- or tetraparesis – no. (%) 8 (57.1) 0/12 (0.0) 6 (37.5)
Cranial nerve palsy – no. (%) 1 (7.1) 2 (15.4) 3 ( 18.8)
CSF – median (IQR)
Leukocytes – cells/mL* 76 (6–272) 46 (24–188) 14 (2–26)
Percentage of lymphocytes 49 (16–70) 70 (58–96) 70 (50–100)
Protein – g/dL 140 (87–235) 151 (105–245) 130 (90–300)
CSF:blood glucose ratio ** 0.13 (0.06–0.43) 0.20 (0.09–0.41) 0.40 (0.33–0.53)
Blood examination
CD4 cell count (cells/mL) – range *** 2–98 4–45 9–30
Titer of toxo-IgG .1:300 5/9 (55%) 3/10 (30%) 11/11 (100%)
Radiological Examination
Abnormal Chest X-ray 8/11 (66.7%) 4/9 (44.4%) 5/10 (50.0%)
Patients with combined TB-toxoplasmosis (n = 5), combined TB-Cryptococcus (n = 2), and no definite diagnosis (n = 14) were excluded from the table. Data are
presented as no. of patients/no. evaluated (%) unless stated otherwise.
GCS =Glasgow Coma Scale.
*significantly different: TB vs. toxoplasmosis (p = .01); cryptococcosis vs. toxoplasmosis (p = .02).
**significantly different: TB vs. toxoplasmosis (p = .03), cryptococcosis vs. toxoplasmosis (p = .02).
***CD4 cell counts were only available for 16 patients with definite diagnoses.
doi:10.1371/journal.pntd.0001994.t001
Figure 1. CSF characteristics according to causative pathogen. CSF cell count (A), protein concentration (B) and CSF:blood glucose ratio (C)
for cases with confirmed toxoplasmosis (N), crypotoccococis (&), and tuberculosis (m). Toxo= toxoplasmosis; crypto = cryptococcosis; TB = TB
meningitis.
doi:10.1371/journal.pntd.0001994.g001
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Table 2. Line list of all patients.
No Age Sex CSF examination* Causative pathogen Diagnosis**
Cell number Protein Glucose ratio ToxoQ TBe Crypton
1 31 M 4 26 0.33 pos neg neg toxoplasmosis
2 30 M 17 100 0.35 pos neg neg toxoplasmosis
3 33 M 18 160 n/a pos neg neg toxoplasmosis
4 18 F 11 150 n/a pos neg neg toxoplasmosis
5 29 F 2 90 0.32 pos neg neg toxoplasmosis
6 24 F 1 300 0.54 pos neg neg toxoplasmosis
7 28 M 13 630 0.4 pos neg neg toxoplasmosis
8 19 F 22 310 0.33 pos neg neg toxoplasmosis
9 30 M 49 130 0.83 pos neg neg toxoplasmosis
10 36 M 1 60 0.58 pos neg neg toxoplasmosis
11 33 M 30 434 0.32 pos neg neg toxoplasmosis
12 35 F 14 95 0.52 pos neg neg toxoplasmosis
13 32 M 26 131 0.5 pos neg neg toxoplasmosis
14 30 M 180 100 0.43 pos neg neg toxoplasmosis
15 34 M 0 50 0.38 pos neg neg toxoplasmosis
16 32 M n/a n/a n/a pos neg neg toxoplasmosis
17 25 F 143 100 0.13 neg pos neg TB
18 31 M 696 39 0.07 neg pos neg TB
19 30 M 7 260 0.06 neg pos neg TB
20 21 F 105 700 0.05 neg pos neg TB
21 52 M 193 190 0.55 neg pos neg TB
22 29 M 1120 n/a 0.03 neg pos neg TB
23 32 M 104 160 0.04 neg pos neg TB
24 30 M 48 40 0.24 neg pos neg TB
25 28 M 507 6980 0.1 neg pos neg TB
26 23 F 0 73 0.4 neg pos neg TB
27 31 M 26 140 n/a neg pos neg TB
28 40 M 4 112 0.47 neg pos neg TB
29 56 M 0 100 0.4 neg pos neg TB
30 29 M 10 210 n/a neg pos neg TB
31 31 M 109 120 0.64 pos pos neg TB-toxo
32 39 M 919 630 0.04 pos pos neg TB-toxo
33 22 M 13 10 0.25 pos pos neg TB-toxo
34 31 M 0 200 0.43 pos pos neg TB-toxo
35 23 F 23 64 0.46 pos pos neg TB-toxo
36 27 M 34 200 0.43 neg neg pos Cryptococcosis
37 30 M 2 22 0.01 neg neg pos Cryptococcosis
38 27 M 419 110 0.06 neg neg pos Cryptococcosis
39 30 M 167 120 0.2 neg neg pos Cryptococcosis
40 38 M 20 230 0.12 neg neg pos Cryptococcosis
41 32 M 209 610 0.01 neg neg pos Cryptococcosis
42 25 F 28 70 0.4 neg neg pos Cryptococcosis
43 32 M 49 100 0.15 neg neg pos Cryptococcosis
44 36 M 46 270 0.51 neg neg pos Cryptococcosis
45 29 M 3 200 0.17 neg neg pos Cryptococcosis
46 22 F 35 151 0.38 neg neg pos Cryptococcosis
47 32 M 248 130 n/a neg neg pos Cryptococcosis
48 32 M 92 260 0.34 neg neg pos Cryptococcosis
Cerebral Toxoplasmosis Mimicking TB Meningitis
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between patients with toxoplasmosis, cryptococcal and tuber-
culosis CNS infection.
Patients with confirmed cryptococcosis received amphotericine
B, followed by fluconazole; all others received empiric tuberculosis
treatment combined with adjunctive corticosteroids [13]. No
toxoplasmosis treatment was given, as T. gondii PCR was
performed retrospectively and was not available at time of
presentation. Eight patients were lost to follow up and were not
included in Kaplan Meier analysis. Mortality among those with
positive CSF T. gondii PCR was 2.16-fold (95% CI 1.04–4.47)
higher compared to those who had a negative PCR result; median
survival was 7 days for toxoplasmosis, 7 days for tuberculosis
meningitis, 110 days for cryptococcosis, and 32 days for patients
with an unknown cause of meningitis (Figure 2).
Discussion
In our cohort of HIV-infected patients presenting with clinical
signs and symptoms of CNS infection, CSF T. gondii PCR was
positive in 32.8% of patients, sometimes in conjunction with
tuberculosis. In the absence of CT or MRI of the brain,
toxoplasmosis could not be distinguished from tuberculosis or
cryptococcosis. Mortality in this cohort of newly diagnosed and
advanced HIV infection was extremely high and associated with a
positive T. gondii PCR.
Cerebral toxoplasmosis typically causes space occupying
lesion(s), leading to subacute or acutely developing confusion,
with or without focal neurological deficits [14]. In the absence of
CT or MRI of the brain, common findings like headache, fever,
hemiparesis and decreased level of consciousness [10] may mimic
those of meningitis [4,15–17]. In previous series of cerebral
toxoplasmosis [18,19], meningeal signs have been reported in 3 to
16% of the patients, although in many reports neck stiffness is not
mentioned [14]. Although rare, cases of spinal cord toxoplasmosis
have also been reported [20]. No typical mass lesions were found
in 6 patients with an available CT scan. This is not surprising, as
this study depended on the availability of CSF samples, that would
not have been obtained if typical mass lesions had been found.
We used T. gondii PCR for diagnosis of cerebral toxoplasmosis.
In previous studies CSF T. gondii PCR had a sensitivity of 50–60%
to confirm cerebral toxoplasmosis in HIV-infected patients
[21,22]. The sensitivity is possibly higher among patients with
meningoencephalitis compared to those with space-occupying
lesions only, but this has not been examined. Specificity of T. gondii
Table 2. Cont.
No Age Sex CSF examination* Causative pathogen Diagnosis**
Cell number Protein Glucose ratio ToxoQ TBe Crypton
49 27 M 0 n/a 0.16 neg pos pos TB-crypto
50 34 M 0 120 0.27 neg pos pos TB-crypto
51 30 F 0 44 0.39 neg neg neg unknown
52 27 M 0 180 0.49 neg neg neg Unknown
53 33 M 259 110 0.57 neg neg neg Unknown
54 32 M 2 130 0.48 neg neg neg Unknown
55 30 M n/a n/a n/a neg neg neg Unknown
56 28 M 143 9850 0.04 neg neg neg Unknown
57 30 M 146 40 0.19 neg neg neg Unknown
58 36 M 17 16 0.51 neg neg neg Unknown
59 24 M 0 30 0.6 neg neg neg Unknown
60 29 M 43 44 0.21 neg neg neg Unknown
61 39 M 18 n/a 0.24 neg neg neg Unknown
62 32 M 184 480 0.08 neg n/a neg Unknown
63 28 M 298 317 0.34 neg neg neg Unknown
64 34 M 166 133 n/a neg n/a neg Unknown
M=male; F = female; pos = positive; neg= negative; n/a = not available.
*cell numbers are in cells/mL; protein in mg/dL; glucose ratio = CSF glucose:blood glucose.
**TB-toxo = tuberculosis and toxoplasmosis, TB-crypto = tuberculosis and cryptococcosis.
Qtoxoplasmosis, based on toxoplasma PCR;
eTB meningitis, based on either culture or real time PCR;
ncryptococcosis based on either direct staing, culture, or antigen testing.
doi:10.1371/journal.pntd.0001994.t002
Figure 2. Kaplan Meier survival estimates. Patients with available
long term follow up data: Toxoplasmosis (n = 14), Cryptococcosis
(n = 13), TB meningitis (n = 14), no diagnosis (n = 13).
doi:10.1371/journal.pntd.0001994.g002
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PCR is high, between 97 and 100% [22–24]. The positivity rate of
32.8% in our study might therefore be an underestimate,
especially in the category of patients in whom no other pathogen
was isolated despite extensive microbiological testing.
In our cohort, toxoplasmosis could not be distinguished
clinically from tuberculosis and cryptococcosis. From our previous
series [4], CSF samples were available for the current study for
36/47 HIV-infected patients. Ten out of 17 patients who were
diagnosed with ‘probable TB meningitis’ and ‘unknown’ in the
previous study were found to have a positive T. gondii PCR (and no
bacteriological confirmation of tuberculosis) in the current study.
Diagnosis of cerebral toxoplasmosis is usually based on clinical
findings and CT or MRI of the brain. However, if cerebral
imaging is lacking, toxoplasmosis may not be considered. Positive
toxoplasma serology, which has a high sensitivity but very poor
specificity, is helpful to exclude but not to confirm cerebral
toxoplasmosis, although some reports suggest that high toxoplas-
ma IgG titers are only found in patients with symptomatic
toxoplasmosis [25]. Indeed, in our study, patients with a positive
T. gondii PCR had a higher IgG titers compared to those who had
a negative PCR. An autopsy study from India provides further
support for the notion that cerebral toxoplasmosis is not always
considered; among 233 HIV patients, toxoplasmosis accounted for
6.8% of deaths, but in none of these cases toxoplasmosis had been
suspected clinically [26].
The incidence of cerebral toxoplasmosis varies between
countries [14] and is related to the seroprevalence of toxoplasmosis
in the general population [19,25]. In the United States,
toxoplasma seroprevalence varies from 3% to 30%, whereas in
France 73%–90% of the population is infected [10]. Reported
seroprevalence rates were varied from 13–31% in the general
population, and 45–68% in HIV patients in studies from several
developing countries [8,27,28]. In our study, 78% of patients had
detectable toxoplasma IgG, but this does not reflect the
seroprevalence in the general population or among unselected
HIV-infected patients, as only meningitis patients were examined.
Mortality in this cohort of patients was very high, higher
compared to reported rates in other series [8,9,29]. One
explanation is that patients mostly presented with advanced and
untreated HIV infection. In addition, no toxoplasmosis treatment
was provided, as PCR was done retrospectively on archived
samples. In our previous study, HIV infection was associated with
a 2.5-fold increased mortality among patients presenting with
meningitis [4]. Data from the current study suggests that this may
is at least in part attributable to a high prevalence of (unrecognized
and untreated) toxoplasmosis. Future studies should examine the
benefit of timely diagnosis and/or empiric treatment of toxoplas-
mosis for patients in settings like ours. Empiric treatment for
subacute meningitis in HIV-infected patients should probably also
include tuberculosis, which is difficult to exclude as culture is slow
and microscopy and commercial PCR assays have insufficient
sensitivity [30].
Our study suffers from several limitations. Most importantly, no
CT or MRI of the brain could be performed. In addition, clinical
data, CD4 cell counts and other laboratory parameters were
missing in a number of patients. Despite these limitations the data
strongly suggest that toxoplasmosis should be included in the
differential diagnosis of HIV-infected with clinically suspected
subacute meningitis, and that molecular testing or empiric
treatment for toxoplasmosis should be considered in these patients,
especially if no CT or MRI can be performed. Obviously, timely
diagnosis and treatment of HIV will help prevent this severe
opportunistic infection.
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